Related Experiment Video
Updated: Sep 21, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
Ryota Masuzaki1, Tatsuo Kanda1, Reina Sasaki1
1Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Itabashi, Tokyo 173-8610, Japan.
Abstract:
Cytokines are secreted soluble glycoproteins that regulate cellular growth, proliferation, and differentiation. Suppressors of cytokine signaling (SOCS) proteins negatively regulate cytokine signaling and form a classical negative feedback loop in the signaling pathways. There are eight members of the SOCS family. The SOCS proteins are all comprised of a loosely conserved N-terminal domain, a central Src homology 2 (SH2) domain, and a highly conserved SOCS box at the C-terminus. The role of SOCS proteins has been implicated in the regulation of cytokines and growth factors in liver diseases. The SOCS1 and SOCS3 proteins are involved in immune response and inhibit protective interferon signaling in viral hepatitis. A decreased expression of SOCS3 is associated with advanced stage and poor prognosis of patients with hepatocellular carcinoma (HCC). DNA methylations of SOCS1 and SOCS3 are found in HCC. Precise regulation of liver regeneration is influenced by stimulatory and inhibitory factors after partial hepatectomy (PH), in particular, SOCS2 and SOCS3 are induced at an early time point after PH. Evidence supporting the important role of SOCS signaling during liver regeneration also supports a role of SOCS signaling in HCC. Immuno-oncology drugs are now the first-line therapy for advanced HCC. The SOCS can be potential targets for HCC in terms of cell proliferation, cell differentiation, and immune response. In this literature review, we summarize recent findings of the SOCS family proteins related to HCC and liver diseases.
Insights
Suppressors of cytokine signaling (SOCS) proteins regulate cell growth and immune responses. This review highlights SOCS proteins as potential therapeutic targets for hepatocellular carcinoma (HCC) and other liver diseases.
Area of Science:
- Molecular Biology
- Immunology
- Hepatology
Background:
- Cytokines are crucial for cell growth and differentiation, with Suppressors of Cytokine Signaling (SOCS) proteins acting as negative regulators.
- The SOCS family comprises eight members, each with distinct roles in cellular signaling pathways.
- SOCS proteins are implicated in regulating cytokine and growth factor signaling in various liver diseases, including viral hepatitis and hepatocellular carcinoma (HCC).
Purpose of the Study:
- To review recent findings on the role of SOCS family proteins in liver diseases, with a focus on hepatocellular carcinoma (HCC).
- To explore the potential of SOCS proteins as therapeutic targets for HCC, considering their influence on cell proliferation, differentiation, and immune response.
Main Methods:
- Literature review summarizing recent research on SOCS proteins in liver diseases and HCC.
- Analysis of the involvement of specific SOCS proteins (SOCS1, SOCS3, SOCS2) in immune response, liver regeneration, and HCC development.
Main Results:
- SOCS1 and SOCS3 are involved in immune response and inhibit interferon signaling in viral hepatitis.
- Decreased SOCS3 expression correlates with advanced HCC stage and poor prognosis; DNA methylation of SOCS1 and SOCS3 is observed in HCC.
- SOCS2 and SOCS3 are induced early during liver regeneration after partial hepatectomy (PH), suggesting a role in liver repair processes.
Conclusions:
- SOCS signaling plays a significant role in liver regeneration and is implicated in the pathogenesis of HCC.
- SOCS proteins represent promising therapeutic targets for HCC, offering potential for modulating cell proliferation, differentiation, and immune responses in the tumor microenvironment.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The JAK-STAT Signaling Pathway
Regulation of Hematopoietic Stem Cells
Inhibition of Cdk Activity

